Skip to content

Effect of esketamine on postoperative sleep and chronic pain in patients undergoing thoracoscopic pulmonary resection: a randomized, controlled, double-blind prospective study

Effect of esketamine on postoperative sleep and chronic pain in patients undergoing thoracoscopic pulmonary resection: a randomized, controlled, double-blind prospective study - Effect of esketamine in thoracoscopic pneumonectomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095258
Enrollment
Unknown
Registered
2025-01-03
Start date
2024-12-05
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative sleep disorders

Interventions

low esketamine group (E1 group):Esketamine was given 0.5mg·kg-1 at the time of anesthesia induction, followed by 0.25 mg·kg-1·h-1 pumping injection immediately until the end of the operation.
high esketamine group (E2 group):Esketamine was given 0.5mg·kg-1 at the time of anesthesia induction, followed by 0.5 mg·kg-1·h-1 pumping injection immediately until the end of the operation.
Blank control group:Conventional general anesthesia induction + equal volume normal saline + conventional anesthesia + intraoperative continuous pumping injection of equal volume normal saline until t

Sponsors

The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1)18 years old = age = 65 years old (2) ASA Class I or II (3) Proposed thoracoscopic lung resection surgery (4) Sign the informed consent form

Exclusion criteria

Exclusion criteria: (1) Allergic to anesthesia drugs (2) History of congestive heart failure (3) Severe arrhythmia exists (4) Presence of pre excitation syndrome (5) Existence of liver failure (6) Existence of renal failure (7) Previous mental illnesses such as anxiety, depression, or sleep disorders (8) I am currently taking psychiatric medication (9) Other reasons why researchers believe it is not appropriate to participate in this experiment

Design outcomes

Primary

MeasureTime frame
Athens Insomnia Scale;Numerical Rating Scale;vital signs;

Secondary

MeasureTime frame
Incidence of postoperative nausea and vomiting;Whether there is coughing and coughing score after extubation to PACU exit;PACU staying time;General information including age, sex, body mass index, and duration of surgery;

Countries

China

Contacts

Public ContactShangguan Wangning

Wenzhou Medical University Affiliated Stomatological Hospital

sgwning@163.com+86 135 8763 7891

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026